Article info
PDFReview
How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer
- Dr M Sobrinho-Simões, IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), R. Roberto Frias s/n, 4200-265 Porto, Portugal; ssimoes{at}ipatimup.pt
Citation
How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer
Publication history
- Accepted December 28, 2008
- First published January 15, 2009.
Online issue publication
August 10, 2020
Article Versions
- Previous version (10 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 The BMJ Publishing Group and the Association of Clinical Pathologists